These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30340616)

  • 1. Disrupting USP5/Cav3.2 interactions protects female mice from mechanical hypersensitivity during peripheral inflammation.
    Gadotti VM; Zamponi GW
    Mol Brain; 2018 Oct; 11(1):60. PubMed ID: 30340616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain.
    Garcia-Caballero A; Gadotti VM; Chen L; Zamponi GW
    Mol Pain; 2016; 12():. PubMed ID: 27130589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2-USP5 interactions in the pain pathway.
    Stemkowski PL; Garcia-Caballero A; Gadotti VM; M'Dahoma S; Chen L; Souza IA; Zamponi GW
    Mol Pain; 2017; 13():1744806917724698. PubMed ID: 28741432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain.
    Gadotti VM; Caballero AG; Berger ND; Gladding CM; Chen L; Pfeifer TA; Zamponi GW
    Mol Pain; 2015 Mar; 11():12. PubMed ID: 25889575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Synthetically Accessible Small-Molecule Inhibitor of USP5-Cav3.2 Calcium Channel Interactions with Analgesic Properties.
    Garcia-Caballero A; Gadotti VM; Ali MY; Bladen C; Gambeta E; Van Humbeck JF; MacCallum JL; Zamponi GW
    ACS Chem Neurosci; 2022 Feb; 13(4):524-536. PubMed ID: 35113527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icariside II, a Prenyl-Flavonol, Alleviates Inflammatory and Neuropathic Pain by Inhibiting T-Type Calcium Channels and USP5-Cav3.2 Interactions.
    Ali MY; Gadotti VM; Huang S; Garcia-Caballero A; Antunes FTT; Jung HA; Choi JS; Zamponi GW
    ACS Chem Neurosci; 2023 May; 14(10):1859-1869. PubMed ID: 37116219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity.
    García-Caballero A; Gadotti VM; Stemkowski P; Weiss N; Souza IA; Hodgkinson V; Bladen C; Chen L; Hamid J; Pizzoccaro A; Deage M; François A; Bourinet E; Zamponi GW
    Neuron; 2014 Sep; 83(5):1144-58. PubMed ID: 25189210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMOylation regulates USP5-Cav3.2 calcium channel interactions.
    Garcia-Caballero A; Zhang FX; Chen L; M'Dahoma S; Huang J; Zamponi GW
    Mol Brain; 2019 Aug; 12(1):73. PubMed ID: 31455361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPV1 Nociceptor Activity Initiates USP5/T-type Channel-Mediated Plasticity.
    Stemkowski P; García-Caballero A; Gadotti VM; M'Dahoma S; Huang S; Black SAG; Chen L; Souza IA; Zhang Z; Zamponi GW
    Cell Rep; 2016 Dec; 17(11):2901-2912. PubMed ID: 27974205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of Ca
    Joksimovic SL; Joksimovic SM; Tesic V; García-Caballero A; Feseha S; Zamponi GW; Jevtovic-Todorovic V; Todorovic SM
    Sci Signal; 2018 Aug; 11(545):. PubMed ID: 30154101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.
    Berger ND; Gadotti VM; Petrov RR; Chapman K; Diaz P; Zamponi GW
    Mol Pain; 2014 Dec; 10():77. PubMed ID: 25481027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of Ca
    Tomita S; Sekiguchi F; Deguchi T; Miyazaki T; Ikeda Y; Tsubota M; Yoshida S; Nguyen HD; Okada T; Toyooka N; Kawabata A
    Toxicology; 2019 Feb; 413():33-39. PubMed ID: 30552955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of Ca
    Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
    Eur J Pharmacol; 2020 Nov; 887():173576. PubMed ID: 32949597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin-mediated inhibition of Cav3.2 T-type Ca
    Zhang Y; Ji H; Wang J; Sun Y; Qian Z; Jiang X; Snutch TP; Sun Y; Tao J
    J Pineal Res; 2018 May; 64(4):e12476. PubMed ID: 29437250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
    Maeda Y; Aoki Y; Sekiguchi F; Matsunami M; Takahashi T; Nishikawa H; Kawabata A
    Pain; 2009 Mar; 142(1-2):127-32. PubMed ID: 19167819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colocalization of insulin-like growth factor-1 receptor and T type Cav3.2 channel in dorsal root ganglia in chronic inflammatory pain mouse model.
    Lin SF; Yu XL; Wang B; Zhang YJ; Sun YG; Liu XJ
    Neuroreport; 2016 Jul; 27(10):737-43. PubMed ID: 27213932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-derived extracellular vesicles regulates USP5-mediated HDAC2/NRF2 axis to ameliorate inflammatory pain.
    Qu Y; Xu Y; Jiang Y; Yu D; Jiang X; Zhao L
    FASEB J; 2021 Sep; 35(9):e21332. PubMed ID: 34423867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ABT-639 on Cav3.2 channel activity and its analgesic actions in mouse models of inflammatory and neuropathic pain.
    Antunes FTT; Huang S; Chen L; Zamponi GW
    Eur J Pharmacol; 2024 Mar; 967():176416. PubMed ID: 38342359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
    Wen XJ; Xu SY; Chen ZX; Yang CX; Liang H; Li H
    Pharmacology; 2010; 85(5):295-300. PubMed ID: 20453553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc deficiency promotes cystitis-related bladder pain by enhancing function and expression of Ca
    Ozaki T; Matsuoka J; Tsubota M; Tomita S; Sekiguchi F; Minami T; Kawabata A
    Toxicology; 2018 Jan; 393():102-112. PubMed ID: 29129814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.